KingstronBio
PrivateLast Round
Series C
Nov 21, 2021
Total Funding Raised
$66.3M
Company Overview
KingstronBio operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was a Series C round in November 2021.
KingstronBio is a medical device company that develops and manufactures innovative cardiovascular products, including bioprosthetic heart valves, annuloplasty rings, and transcatheter valve systems for structural heart disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KingstronBio Comparables
Compare KingstronBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MitrAssist Lifesciences Limited | 89% | |
| Shanghai New Pulse Medical Technology | 88% | |
| Shanghai Hanyu Medical Technology | 86% |
For institutional investors. Book with your work email.
KingstronBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 21, 2021 | ||||
| Strategic | Jan 1, 2021 | ||||
| Strategic | Sep 29, 2020 | ||||
| Series B | Jan 22, 2018 | ||||
| Series A | Mar 5, 2016 |
For institutional investors. Book with your work email.
KingstronBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| YuanBio Venture Capital | Series A |
| Everbright Financial Holding Asset Management | Series C |
| Jingxu Venture Capital | Series A |
| Panlin Capital | Series C, Strategic |
| Cowin Capital | Series A |
| HongShan Capital Group (HSG) | Series C |
| Tengye Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 21, 2021
$47M round led by HongShan Capital Group.
- Jan 1, 2021
Completed a strategic funding round.
For institutional investors. Book with your work email.
KingstronBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about KingstronBio's valuation, stock price, and market status.
Is KingstronBio a public or private company?
KingstronBio is a private company.
What is the current stock price of KingstronBio?
KingstronBio is a private company, so its shares have no public market price. Caplight tracks KingstronBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is KingstronBio worth (valuation)?
Valuation information for KingstronBio is not publicly available.
Can I buy KingstronBio stock?
KingstronBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was KingstronBio's last funding round?
KingstronBio's most recent funding round was Series C on November 21, 2021.
Who are the main investors in KingstronBio?
Key investors in KingstronBio include HongShan Capital Group (HSG).
Will KingstronBio IPO soon?
No public IPO plans have been announced for KingstronBio.
How can I track KingstronBio secondary market activity?
Caplight tracks bids, offers, and trades in KingstronBio's shares on secondary markets.